nannan shi1, jianqing sun2, Fei Shan1, Yiying qin1, Zecheng yang1, Weibo chen3, and yuxin shi1
1Shanghai Public Health Clinical Center, Fudan University, shanghai, China, 2Shanghai United Imaging Research Institute of Intelligent Imaging, shanghai, China, 3Philips Healthcare, shanghai, China
Synopsis
To further develop
and validate a radiomics-based model from liver T2WI images for staging liver
fibrosis.
Introduction
Liver fibrosis is mainly
caused by hepatitis virus, alcohol, drugs and poisons,
autoimmune liver disease and other chronic factors
that stimulate the liver. Advanced liver fibrosis results in cirrhosis, portal
hypertension and even liver failure1,2. Liver fibrosis may be potentially modified by treatment.
Hence, early diagnosis, staging and therapy to decrease or halt fibrosis
progression or reverse the fibrosis are urgently needed for chronic liver
disease.
Recently, several studies
based on radiologic analysis of computed tomography (CT), magnetic resonance
imaging (MRI) and ultrasound (US) have been widely
proposed for the detection, evaluation and surveillance of liver fibrosis. Radiomics
aims to quantify phenotypic characteristics on medical imaging by using
automated algorithms, which can perform diagnostic or predictive tasks. Our
research aims to develop and validate radiomics-based machine learning
techniques for staging liver fibrosis by using T2WI images.Methods
291 patients (58, 53,
45, and 135 patients with fibrosis stages of S1, S2, S3, and S4, respectively) with liver disease who underwent
abdomen MRI and confirmed of liver fibrosis within 3 months with hepatectomy or
biopsy between January 2017 and June 2019 in Shanghai Public Health
Clinical Center were enrolled in this retrospective study. For each patient, 1688 radiomic
features were extracted from T2WI images. Features with predictive values were
retained using Spearman correlation analysis and LASSO (least
absolute shrinkage and selection operator). Three diagnostic models were built
using Linear SVC
Classifier with the selected radiomics features to predict significant fibrosis (≥S2),
advanced fibrosis (≥S3), and cirrhosis (S4), respectively. Finally, we
validated the model performance on independent test datasets.Results
The AUC of the
test datasets for diagnosing significant fibrosis (≥S2), advanced fibrosis
(≥S3), and cirrhosis (S4) is 0.82, 0.88, and 0.88, respectively. In the test set to differentiate
significant fibrosis, The corresponding accuracy, F1, sensitivity, specificity,
PPV, NPV, FPR, FNR and FDR of the model are 0.76, 0.83, 0.76, 0.78, 0.93, 0.45,
0.22, 0.24 and 0.07. At the stage of advanced fibrosis, the performance in test set was accuracy of 0.88, F1 of 0.83, sensitivity
of 0.85, specificity of 0.83, PPV of 0.81, NPV of 0.87, FPR of 0.17, FNR of
0.15 and FDR of 0.19. According to the statistical analysis of cirrhosis, the classifier achieved accuracy of 0.81, F1 of 0.79, sensitivity of
0.78, specificity of 0.83, PPV of 0.80, NPV of 0.81, FPR of 0.17, FNR of 0.22
and FDR of 0.20 in test set.Discussion
The typical
patterns of liver fibrosis include fine reticular and coarse linear patterns,
with the fibrotic bands outlining foci of regenerative nodules. Radiologic images play a crucial role in
the assessment of liver fibrosis. Studies have shown that the MR images had an
advantage over CT images in classification of liver fibrosis. The fibrotic
bands of tissue frequently show linear and reticular hyperintense signals on
T2WI or low intensity tramline or rings at portal phase on dynamic
contrast-enhanced imaging, possibly due to intrahepatic inflammatory exudate,
altered hemodynamics or abnormal lymphatic formation and reflux3,4.
Radiomics has the
potential to expand the capabilities of liver radiology beyond the scope of
traditional visual image assessment, which allows for a comprehensive analysis
of morphologic and textural change in the liver.
It has been
previously reported that texture analysis of MR images produced
misclassification rates of 28.46%, 35.77% and 20.33% for fibrosis staging in
T2WI, T1WI and Gd-EOB-DTPA-enhanced hepatocyte-phase imaging, respectively5.
In he’s
study6,
a support vector machine learning model incorporating clinical and T2-weighted
radiomics features have fair-to-good diagnostic performance for categorically
classifying liver stiffness. Rather than using a contrast agent, we applied a
radiomics-based machine model of T2WI images in the interest of simplicity and
safety. In our study, the model diagnosed significant fibrosis (≥S2), advanced
fibrosis (≥S3), and cirrhosis (S4) with AUCs of 0.82, 0.88, and 0.88,
respectively.
These diagnostic
performances are comparable to several previous studies investigating the
possibilities of deep learning to determine liver fibrosis stage.Conclusion
Radiomics analysis
of T2WI image is a new non-invasive method that allows for accurate diagnosis
of the liver fibrosis stages.Acknowledgements
The study was supported by the
grants from Shanghai Hospital Development Center (No. SHDC12019128); Shanghai public
health clinical center (KY-GW-2021-11).References
1.Bataller R, Brenner DA. Liver fibrosis. J
Clin Invest 2005;115:209-18.
2.Shan L, Liu Z, Ci L, Shuai C, Lv X, Li J.
Research progress on the anti-hepatic fibrosis action and mechanism of natural
products. Int Immunopharmacol 2019;75:105765.
3.Chundru S, Kalb B, Arif-Tiwari H, Sharma P,
Costello J, Martin DR. MRI of diffuse liver disease: characteristics of acute
and chronic diseases. Diagn Interv Radiol 2014;20:200-8.
4.Shu J, Zhao JN, Han FG, Tang GC, Chen X.
Chronic hepatitis B: correlation of abnormal features on T2-weighted imaging
and dynamic contrast-enhanced imaging with hepatic histopathology. Radiol Med
2017;122:807-813.
5. Wu Z, Matsui O, Kitao A, Kozaka K, Koda W,
Kobayashi S, et al. Hepatitis C related chronic liver cirrhosis: feasibility of
texture analysis of MR images for classification of fibrosis stage and
necroinflammatory activity grade. PLoS One 2015;10:e0118297.
6. He L, Li H, Dudley JA, Maloney TC, Brady
SL, Somasundaram E, et al. Machine Learning Prediction of Liver Stiffness Using
Clinical and T2-Weighted MRI Radiomic Data. AJR Am J Roentgenol
2019;213:592-601.